LAVAL, Quebec, July 15, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it plans to host a conference call and live webcast on August 9, 2016 to discuss second quarter 2016 financial results.
Conference Call Details:
Date | Tuesday, August 9, 2016 |
Time | 8:00 a.m. ET |
Webcast | |
Participant Event Dial-in | (877) 876-8393 (North America) |
(973) 200-3961 (International) | |
Participant Passcode | 48835456 |
Replay Dial-in | (855) 859-2056 (North America) |
(404) 537-3406 (International) | |
Replay Passcode | 48835456 (Replay available until August 17, 2016) |
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.
Contact Information:
Laurie W. Little
laurie.little@valeant.com
or
Elif McDonald
elif.mcdonald@valeant.com
514-856-3855
877-281-6642 (toll free)
Media:
Renée Soto
or
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.
212-687-8080
Logo - http://photos.prnewswire.com/prnh/20101025/LA87217LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-announces-second-quarter-results-conference-call-date-and-details-300299291.html
SOURCE Valeant Pharmaceuticals International, Inc.
